Epistemic in/justice in patient participation. A discourse analysis of the Dutch ME/CFS Health Council advisory process.
de Boer, Marjolein Lotte · Sociology of health & illness · 2021 · DOI
Quick Summary
This study looked at how ME/CFS patients were involved in advising the Dutch Health Council between 2013-2018. The researchers found that patient representatives mainly shared medical/scientific knowledge about ME/CFS as a physical illness, avoiding discussion of psychological factors. While this approach helped patients be taken more seriously, it may have actually limited what kinds of knowledge and experiences patients could contribute, and it might reinforce incomplete understandings of the disease.
Why It Matters
This study highlights a paradox in patient advocacy: while emphasizing the physical nature of ME/CFS is necessary to counter stigma, it may inadvertently narrow the types of knowledge patients can legitimately contribute to research and policy decisions. Understanding this tension is crucial for creating truly inclusive participatory processes that honor the full complexity of patient experience and expertise.
Observed Findings
Patient representatives predominantly presented biomedical, quantifiable knowledge about ME/CFS rather than qualitative or lived-experience perspectives.
The biomedicalized framing enhanced patient credibility and validation but limited the range of acceptable knowledge types within the participatory process.
Patient representatives framed diagnostic criteria, research priorities, and treatments primarily through objective, measurable parameters.
Inferred Conclusions
Biomedicalized patient participation can be epistemically emancipatory in validating patient experience but simultaneously constraining by narrowing what counts as legitimate knowledge.
Participatory practices risk sustaining reductive understandings of ME/CFS when they privilege biomedical over other forms of patient knowledge.
More inclusive participatory practices should explicitly create space for diverse forms of patient expertise beyond biomedical frameworks.
Remaining Questions
Did the patient representatives' biomedical framing in the advisory process actually influence the Health Council's final recommendations and ME/CFS policy outcomes?
How did individual patient representatives experience the tension between needing to establish biomedical credibility and wanting to contribute other forms of knowledge?
What This Study Does Not Prove
This discourse analysis does not prove that biomedical framing by patient representatives was harmful overall or that it failed to improve ME/CFS policy outcomes. The study examines what was said in advisory processes but does not measure whether this participation actually changed health policy, research funding, or clinical practice. It also does not assess whether patients themselves felt their participation was constrained or meaningful.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →